Abbott's panbio rapid antigen test receives ce mark for asymptomatic screening and self-administered sample collection with nasal swab

Abbott park, ill., jan. 26, 2021 /prnewswire/ -- abbott (nyse: abt) announced today it has received ce mark for two new uses of its panbio™ covid-19 ag rapid test device for the detection of the sars-cov-2 virus: asymptomatic testing and self-swabbing. panbio covid-19 ag's label has been...
ABT Ratings Summary
ABT Quant Ranking